Skip to main content
. 2018 Mar 29;8:5402. doi: 10.1038/s41598-018-23656-0

Figure 2.

Figure 2

OMVs from β-lactam-resistant Escherichia coli can protect β-lactam-susceptible Escherichia coli and fully rescue them from β-lactam antibiotic-induced growth inhibition. (a) Representative growth profiles of RC85 cells in the presence of growth-inhibiting concentrations of antibiotics. The growth-inhibiting concentrations of antibiotics were: ampicillin, 30 μg/mL; cefoperazone, 4 μg/mL; and cefotaxime, 1.25 μg/mL. The data are presented as means and SEMs of at least three independent experiments. (b) The survival percentages of RC85 cells in the presence of the above-listed growth-inhibiting concentrations of antibiotics and RC85+ OMVs or RC85 OMVs were computed by bacterial counts of cultures at a certain time points (ampicillin, 12 h; cefoperazone and cefotaxime, 24 h). The data are presented as means and SEMs of three independent experiments. *P < 0.05, **P < 0.01, ***P < 0.001, and ****P < 0.0001.